אזיתרומיצין טבע ישראל - עברית - Ministry of Health

אזיתרומיצין טבע

teva pharmaceutical industries ltd, israel - azithromycin - אבקה להכנת תרחיף - azithromycin 200 mg / 5 ml - azithromycin - azithromycin - for infections caused by susceptible organisms :in lower respiratory tract infections including bronchitis and pneumonia, in skin and soft tissue infections, in otitis media and in upper respiratory tract infections including sinusitis and pharyngitis tonsillitis. azithromycin teva is also indicated in the treatment of uncomplicated genital infections due to chlamydia trachomatis.

אזיתרומיצין טבע ישראל - עברית - Ministry of Health

אזיתרומיצין טבע

teva pharmaceutical industries ltd, israel - azithromycin - אבקה להכנת תרחיף - azithromycin 200 mg / 5 ml - azithromycin - azithromycin - for infections caused by susceptible organisms : in lower respiratory tract infections including bronchitis and pneumonia, in skin and soft tissue infections, in otitis media and in upper respiratory tract infections including sinusitis and pharyngitis tonsillitis. azithromycin teva is also indicated in the treatment of uncomplicated genital infections due to chlamydia trachomatis.

טבעפירין ישראל - עברית - Ministry of Health

טבעפירין

teva pharmaceutical industries ltd, israel - acetylsalicylic acid - טבליות עם ציפוי אנטרי - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

טבעפירין ישראל - עברית - Ministry of Health

טבעפירין

teva pharmaceutical industries ltd, israel - acetylsalicylic acid - טבליות עם ציפוי אנטרי - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

טבעפירין ישראל - עברית - Ministry of Health

טבעפירין

teva pharmaceutical industries ltd, israel - acetylsalicylic acid - טבליות עם ציפוי אנטרי - acetylsalicylic acid 100 mg - acetylsalicylic acid

Tevadaptor - Closed drug reconstitution system ישראל - עברית - Ministry of Health

tevadaptor - closed drug reconstitution system

teva medical ltd. - migada - אחות - see attached document : us fda 510(k) k051669 approved indications for use

אטודולק אי.אר. טבע   600 מג ישראל - עברית - Ministry of Health

אטודולק אי.אר. טבע 600 מג

teva pharmaceutical industries ltd, israel - etodolac - טבליה - etodolac 600 mg - etodolac - etodolac - for the management of signs and symptoms of osteoarthritis and rehumatoid arthritis.

רוזובסטטין טבע ® 5 מ"ג ישראל - עברית - Ministry of Health

רוזובסטטין טבע ® 5 מ"ג

teva pharmaceutical indust.ltd - rosuvastatin as calcium 5 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

רוזובסטטין טבע ® 10 מ"ג ישראל - עברית - Ministry of Health

רוזובסטטין טבע ® 10 מ"ג

teva pharmaceutical indust.ltd - rosuvastatin as calcium 10 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

רוזובסטטין טבע ® 20 מ"ג ישראל - עברית - Ministry of Health

רוזובסטטין טבע ® 20 מ"ג

teva pharmaceutical indust.ltd - rosuvastatin as calcium 20 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.